Stock listing
Bioton S.a.
Selected listing: A0D9SD · LS · EUR · DE
Bioton S.a. (Lang & Schwarz: A0D9SD), Health Technology. Latest release May 29, 2026: Bioton Q1 Net Loss At 5.2 Million Zlotys.
- Ticker
- Lang & Schwarz: A0D9SD
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
About Bioton S.a.
The company operates in the biotechnology sector, focusing on the development and production of biopharmaceuticals. Bioton is committed to advancing healthcare solutions through innovative technologies and products.
Latest news from Bioton S.a.
Bioton Q1 Net Loss At 5.2 Million Zlotys
May 29, 2026
Bioton Says Polish Court Declares Chinese Arbitral Award Enforceable
May 27, 2026
Bioton EGM To Vote On Reducing Share Capital To About 8.59 Mln Zlotys From About 1.72 Bln Zlotys
March 16, 2026
Bioton Q4 Net Profit At 1.8 Mln Zlotys
February 27, 2026
Bioton Q3 Net Profit At 4.2 Million Zlotys
October 30, 2025
Research Bioton S.a.
Alternate listings
BIO:GPW
PL · PLN
Alternate listing for Bioton S.a.; the primary context on this page is A0D9SD:LS.
A0D9SD:LSX
DE · EUR
Alternate listing for Bioton S.a.; the primary context on this page is A0D9SD:LS.
0DTR:LSE
GB · PLN
Alternate listing for Bioton S.a.; the primary context on this page is A0D9SD:LS.
7U5:FWB
DE · EUR
Alternate listing for Bioton S.a.; the primary context on this page is A0D9SD:LS.
7U5:SWB
DE · EUR
Alternate listing for Bioton S.a.; the primary context on this page is A0D9SD:LS.